Seseli peucedanoides
Seseli peucedanoides · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Seseli peucedanoides is a botanical species recognized for its unique chemical composition and medicinal potential. The plant's fruits serve as a primary source for extracting valuable compounds such as bergapten and peucedanin. Scientific analysis often utilizes various preparations, including dried fruits and crude petroleum ether extracts obtained through Soxhlet extraction. Research indicates that this extraction method achieves a specific efficiency of 12.28% when processing the plant material. Understanding these chemical profiles is essential for exploring the diverse pharmacological applications of this species.
- Synonyms
- Gasparinia Elegans · Gasparinia Peucedanoides · 22 more
- Common names
- Not available
- Family
- Apiaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Fruit
Classification
Synonyms
Seseli peucedanoides is a botanical subject frequently identified by several different taxonomic names in various scientific records. It is recognized under the synonym Bunium peucedanoides, which highlights its complex classification history. Researchers also refer to this species as Bunium virescens or Carum olympicum depending on the specific botanical context. Furthermore, the plant is linked to the names Cnidium virescens and Foeniculum peucedanoides within certain literature. Understanding these diverse synonyms is essential for ensuring accurate identification and consistent communication in botanical studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Seseli peucedanoides is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida. It further falls into the order Apiales, showcasing its specific evolutionary lineage. As a member of the family Apiaceae, it shares characteristics with many well-known herbaceous plants. Ultimately, this species is distinguished by its placement within the genus Seseli.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Apiales |
| Family | Apiaceae |
| Genus | Seseli |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Seseli peucedanoides is a resilient plant species with a broad geographical reach spanning across several key regions. It is widely distributed throughout the Asia-Temperate zone, with a notable presence in the Caucasus and Transcaucasus. The species also extends its range into Western Asia, specifically flourishing within the landscapes of Iran and Türkiye. Beyond its Asian territories, it can be found reaching into Europe, particularly throughout Eastern Europe and South European Russia. This diverse distribution highlights the plant's ability to adapt to various environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Seseli peucedanoides is a distinctive herb characterized by its specific growth form. This plant typically reaches a height of at least 0.4 m as it matures. Under optimal conditions, the species can grow to a maximum height of 0.9 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Seseli peucedanoides serves as a significant botanical source for the identification of specific chemical compounds. Research into similar Apiaceae species highlights the importance of isolating methoxyfuranocoumarins from plant matrices. Within these biological profiles, Seseli peucedanoides contains Bergapten, a compound of interest for various chemical studies. Additionally, Seseli peucedanoides contains Peucedanin, further enriching its complex phytochemical makeup. Understanding these specific relationships is essential for advancing pharmacological research and effective metabolite separation.
Conditions
Seseli peucedanoides, through the isolated compound 5-methoxypsoralen, demonstrates significant antiproliferative and proapoptotic effects against various cancer cell lines. It effectively treats human colorectal adenocarcinoma by inhibiting the viability and migration of HT-29 and SW620 cells. The plant also shows therapeutic potential against osteosarcoma, specifically exhibiting a strong inhibitory effect on Saos-2 and a moderate effect on HOS cells. Additionally, it has been evaluated for its ability to treat multiple myeloma, though the RPMI8226 and U266 cell lines showed lower sensitivity to the treatment. These biological actions provide important insights into using the plant's compounds to inhibit the growth of therapeutic-resistant cancers.
Preparations
Seseli peucedanoides is prepared as MB fruits to facilitate the isolation of specific bioactive compounds. This plant material is also processed into a crude petroleum ether extract (CPE) using Soxhlet extraction with an efficiency of 12.28%. Researchers utilize the plant material itself for the identification and quantitative analysis of various methoxyfuranocoumarins. Furthermore, the preparation of the CPE allows for the effective separation of metabolites like peucedanin and bergapten through centrifugal partition chromatography. These diverse preparation methods enable the study of the plant's chemical constituents for potential pharmacological applications.
Parts used
Seseli peucedanoides belongs to a botanical group where the fruit serves as a critical component for chemical analysis. While specific research often focuses on related species like Peucedanum tauricum, the presence of the fruit is essential for isolating valuable methoxyfuranocoumarins. These specialized plant parts allow scientists to extract metabolites such as bergapten through advanced chromatographic techniques. Such extractions are vital because these compounds demonstrate significant potential in inhibiting the growth of various therapeutic-resistant cancer cells. Consequently, understanding the relationship between the plant and its fruit is a fundamental step in exploring new pharmacological applications.